Methotrexate vs azathioprine in second-line therapy of sarcoidosis

Chest

Volumn 144, Issue 3, 2013, Pages 805-812

  Vorselaars, Adriane D M ^a   Wuyts, Wim A ^b   Vorselaars, Veronique M M ^a   Zanen, Pieter ^c   Deneer, Vera H M ^a   Veltkamp, Marcel ^a   Thomeer, Michiel ^d   Van Moorsel, Coline H M ^a,c   Grutters, Jan C ^a,c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHOTREXATE; PREDNISONE;

ADULT; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DIFFUSING CAPACITY OF LUNG FOR CARBON DIOXIDE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; EMPYEMA; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HAIR LOSS; HEADACHE; HERPES ZOSTER; HUMAN; IMPOTENCE; INFECTION; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SARCOIDOSIS; SEPSIS; SIDE EFFECT; STOMACH PAIN; THROMBOCYTOPENIA; VITAL CAPACITY;

EID: 84881669350     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1728     Document Type: Article

References (24)

1. Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2005 ;(2): CD001114.
2. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J. 2006 ; 28 (3): 627-636.
3. Schutt AC, Bullington WM, Judson MA. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med. 2010 ; 104 (5): 717-723.
4. Baughman RP, Nunes H. Therapy for sarcoidosis: evidencebased recommendations. Expert Rev Clin Immunol. 2012 ; 8 (1): 95-103.
5. Kiltz U, Braun J. Use of methotrexate in patients with sarcoidosis. Clin Exp Rheumatol. 2010 ; 28 (5)(suppl 61): S183-S185.
6. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990; 299(3): 153-157.
7. Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly lowdose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991 ; 24 (3): 451-454.
8. Vucinic VM. What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med. 2002 ; 8 (5): 470-476.
9. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000 ; 17 (1): 60-66.
10. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995 ; 155 (8): 846-851.
11. Pacheco Y, Marechal C, Marechal F, Biot N, Perrin Fayolle M. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis. 1985 ; 2 (2): 107-113.
12. Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999 ; 14 (5): 1117-1122.
13. Lewis SJ, Ainslie GM, Bateman ED. Effi cacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999 ; 16 (1): 87-92.
14. Baughman RP, Drent M, Kavuru M, et al; Sarcoidosis Investigators. Infl iximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006 ; 174 (7): 795-802.
15. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Soci ety/European Respiratory Society/World Association of Sar coidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999 ; 16 (2): 149-173.
16. Hedeker D, Gibbons RD. Longitudinal Data Analysis. Hoboken, NJ : John Wiley & Sons ; 2006.
17. Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford). 2007 ; 46 (7): 1157-1160.
18. Arnold MH, O'Callaghan J, McCredie M, Beller EM, Kelly DE, Brooks PM. Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study. Br J Rheumatol. 1990; 29(2): 120-125.
19. Pagnoux C, Mahr A, Hamidou MA, et al; French Vasculitis Study Group. Azathioprine or methotrexate maintenance for ANCAassociated vasculitis. N Engl J Med. 2008 ; 359 (26): 2790-2803.
20. Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1997 ; 14 (2): 121-130.
21. Medicijnkosten website. http:// www.medicijnkosten.nl. Accessed May 26, 2012.
22. Belgium Centre for Farmacotherapeutic Information website. http:// www.bcfi .be. Accessed May 26, 2012.
23. Goossens HA, Ferech M, Vander Stichele R, Elseviers M ; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005 ; 365 (9459): 579-587.
24. Dong XW, Zheng Q, Zhu MM, Tong JL, Ran ZH. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of infl ammatory bowel disease. World J Gastroenterol. 2010 ; 16 (25): 3187-3195.